XOMA
Price:
$27.28
Market Cap:
$319.30M
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.[Read more]
Industry
Biotechnology
IPO Date
1986-06-06
Stock Exchange
NASDAQ
Ticker
XOMA
According to XOMA Corporation’s latest financial reports and current stock price. The company's current PE Ratio is -12.40. This represents a change of 255.65% compared to the average of -3.49 of the last 4 quarters.
The mean historical PE Ratio of XOMA Corporation over the last ten years is -0.57. The current -12.40 PE Ratio has changed 216.21% with respect to the historical average. Over the past ten years (40 quarters), XOMA's PE Ratio was at its highest in in the June 2017 quarter at 46.53. The PE Ratio was at its lowest in in the December 2017 quarter at -55.35.
Average
-0.57
Median
-6.40
Minimum
-31.08
Maximum
35.42
Discovering the peaks and valleys of XOMA Corporation PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 291.49%
Maximum Annual PE Ratio = 35.42
Minimum Annual Increase = -4014.99%
Minimum Annual PE Ratio = -31.08
Year | PE Ratio | Change |
---|---|---|
2023 | -5.20 | -57.67% |
2022 | -12.28 | -182.41% |
2021 | 14.90 | -57.94% |
2020 | 35.42 | -213.98% |
2019 | -31.08 | 291.49% |
2018 | -7.94 | -142.72% |
2017 | 18.58 | -4014.99% |
2016 | -0.47 | -93.75% |
2015 | -7.60 | -24.53% |
2014 | -10.07 | 113.98% |
The current PE Ratio of XOMA Corporation (XOMA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-0.86
5-year avg
0.35
10-year avg
-0.57
XOMA Corporation’s PE Ratio is less than Werewolf Therapeutics, Inc. (-1.64), greater than Edgewise Therapeutics, Inc. (-14.14), less than Decibel Therapeutics, Inc. (-1.94), less than Celcuity Inc. (-7.01), less than C4 Therapeutics, Inc. (-3.44), greater than Third Harmonic Bio, Inc. (-26.95), less than Passage Bio, Inc. (-0.57), less than Acrivon Therapeutics, Inc. Common Stock (-4.23), less than Eliem Therapeutics, Inc. (-3.49), less than TRACON Pharmaceuticals, Inc. (0.03), less than Rezolute, Inc. (-3.80), less than Sio Gene Therapies Inc. (-4.77), less than Vincerx Pharma, Inc. (-0.95), less than Stoke Therapeutics, Inc. (-7.92), greater than Crinetics Pharmaceuticals, Inc. (-15.40), less than Dyne Therapeutics, Inc. (-11.86), greater than Revolution Medicines, Inc. (-13.31), less than Design Therapeutics, Inc. (-5.23), less than Tango Therapeutics, Inc. (-10.13), less than Talaris Therapeutics, Inc. (-0.20), less than Achilles Therapeutics plc (-0.45),
Company | PE Ratio | Market cap |
---|---|---|
-1.64 | $88.28M | |
-14.14 | $1.64B | |
-1.94 | $123.37M | |
-7.01 | $557.67M | |
-3.44 | $374.42M | |
-26.95 | $493.17M | |
-0.57 | $43.48M | |
-4.23 | $250.26M | |
-3.49 | $495.57M | |
0.03 | $194.57K | |
-3.80 | $240.80M | |
-4.77 | $30.70M | |
-0.95 | $22.05M | |
-7.92 | $773.92M | |
-15.40 | $4.03B | |
-11.86 | $3.32B | |
-13.31 | $6.99B | |
-5.23 | $264.42M | |
-10.13 | $1.17B | |
-0.20 | $116.44M | |
-0.45 | $29.58M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like XOMA Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like XOMA Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is XOMA Corporation's PE Ratio?
How is the PE Ratio calculated for XOMA Corporation (XOMA)?
What is the highest PE Ratio for XOMA Corporation (XOMA)?
What is the 3-year average PE Ratio for XOMA Corporation (XOMA)?
What is the 5-year average PE Ratio for XOMA Corporation (XOMA)?
How does the current PE Ratio for XOMA Corporation (XOMA) compare to its historical average?